optimum plasma concentration ranges have been described for lignocaine ( lidocaine ) , procainamide , quinidine and , more recently , also for disopyramide , mexiletine , tocainide and other new antiarrhythmics .
C0023660
lidocaine
C0003195
antiarrhythmics